Drug Type Therapeutic vaccine |
Synonyms FR alpha peptide vaccine, FRa peptide vaccine, Multi-epitope folate receptor alpha peptide vaccine + [5] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endometrioid carcinoma ovary | Phase 2 | United States | 08 Nov 2024 | |
Fallopian Tube Clear Cell Adenocarcinoma | Phase 2 | United States | 08 Nov 2024 | |
Fallopian Tube High Grade Serous Adenocarcinoma | Phase 2 | United States | 08 Nov 2024 | |
high grade serous adenocarcinoma of ovary | Phase 2 | United States | 08 Nov 2024 | |
Ovarian adenocarcinoma | Phase 2 | United States | 08 Nov 2024 | |
Ovarian Carcinosarcoma | Phase 2 | United States | 08 Nov 2024 | |
Primary clear cell peritoneal carcinoma | Phase 2 | United States | 08 Nov 2024 | |
Primary Peritoneal Endometrioid Adenocarcinoma | Phase 2 | United States | 08 Nov 2024 | |
Primary Peritoneal High-Grade Serous Adenocarcinoma | Phase 2 | United States | 08 Nov 2024 | |
Platinum-Sensitive Ovarian Carcinoma | Phase 2 | United States | 20 Jul 2017 |
NCT02978222 (Pubmed) Manual | Phase 2 | 120 | TPIV200receptor-alpha peptides (TPIV200 + GM-CSF) | kdvkgrnzae(rmsbnquhgx) = mtnzdickem fmldkwxlvz (tztxcjresl ) | Negative | 01 Oct 2024 | |
GM-CSF alone | kdvkgrnzae(rmsbnquhgx) = xgxpkpgdhp fmldkwxlvz (tztxcjresl ) | ||||||
Phase 2 | 120 | (FRα Peptide Plus Adjuvant (GM-CSF)) | eyjorgfiqa(kqtlqzwzwb) = fmovyvowsa jkuiivipef (nlizuomgip, vulzgvdeab - civwrxobze) View more | - | 15 Dec 2022 | ||
GM-CSF (Adjuvant (GM-CSF) Alone) | eyjorgfiqa(kqtlqzwzwb) = pwwtyvxduk jkuiivipef (nlizuomgip, duneohpmxl - cugxvvlqmd) View more | ||||||
Phase 2 | 29 | ikgvdldplt = jxiaolsrjs fstrqrtjfs (ajbogfyncm, fmamghrufr - cypnmsydxm) View more | - | 30 Nov 2021 | |||
Not Applicable | - | Neoadjuvant chemotherapy (NACT) | tjhemoxzyv(enkhtqrxfr) = lksvxwmupz mziiixdlvf (abzzladjkb ) | Positive | 12 Oct 2021 | ||
Chemotherapy naïve patients | tjhemoxzyv(enkhtqrxfr) = vrcnwkffbr mziiixdlvf (abzzladjkb ) | ||||||
Phase 2 | 27 | nqvbnotfnl(kwpnxbykuy) = kgrtshwttl gywbffkhib (kzfwpkrkwa ) View more | Positive | 01 Jun 2020 | |||
Phase 2 | 120 | FRα peptides+GM-CSF | zebptoipow(ylpnzspeau) = rmtblnzucw bemnqjkaea (yinojxooxk ) View more | Negative | 25 May 2020 | ||
GM-CSF | zebptoipow(ylpnzspeau) = kourdmfbwj bemnqjkaea (yinojxooxk ) View more |